Corin: A new player in the regulation of salt-water balance and blood pressure

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 6, 2013, Pages 713-722

  Armaly, Zaher ^a   Assady, Suheir ^b   Abassi, Zaid ^c,d  

^a BAR ILAN UNIVERSITY   (Israel)

^b Department of Nephrology ^*  (Israel)

^c Tirat Carmel Mental Health Center   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

corin; edema; hypertension; natriuretic peptides; sodium retention

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CORIN; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; NATRIURETIC PEPTIDE TYPE C; PHOSPHODIESTERASE V; UNCLASSIFIED DRUG;

BLOOD PRESSURE; DIURESIS; DIURETIC ACTIVITY; EXTRACELLULAR SPACE; FLUID BALANCE; GENE MUTATION; GLYCOSYLATION; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HUMAN; HYDRAULIC CONDUCTIVITY; HYPERTENSION; MATERNAL HYPERTENSION; NEPHROTIC SYNDROME; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SODIUM RETENTION; UPREGULATION; WATER RETENTION; ZONA GLOMERULOSA;

BLOOD PRESSURE; DIURESIS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL; NATRIURESIS; NATRIURETIC PEPTIDES; NEPHROTIC SYNDROME; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, PEPTIDE; SERINE ENDOPEPTIDASES; WATER-ELECTROLYTE BALANCE;

EID: 84887020390     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000435609.35789.32     Document Type: Review

References (81)

1. Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 2012; 82:635-642.
2. Chaney E, Shaw A. Pathophysiology of fluid retention in heart failure. Contrib Nephrol 2010; 164:46-53.
3. Skorecki K, Winaver J, Abassi Z. Control of extracellular fluid volume and pathophysiology of edema formation (chapter 19). In: Brenner B, editor. The kidney, 8th ed. Philadelphia, PA: W.B. Saunders; 2008. pp. 398-458.
4. Abassi ZA, Brodsky S, Karram T, et al. Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula. Cardiovasc Res 2001; 15:567-576.
5. Winaver J, Hoffman A, Burnett JC Jr, et al. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988; 254:R776-R784.
6. Abassi Z, Haramati A, Hoffman A, et al. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol 1990; 259:R84-R89.
7. Villarreal D, Freeman RH, Davis JO, et al. Atrial natriuretic factor secretion in dogs with experimental high-output heart failure. Am J Physiol 1987; 252:H692-H696.
8. Villarreal D, Freeman RH. ANF and the renin-angiotensin system in the regulation of sodium balance: longitudinal studies in experimental heart failure. J Lab Clin Med 1991; 118:515-522.
9. Winaver J, Hoffman A, Abassi Z, et al. Does the heart's hormone, ANP, help in congestive heart failure? News Physiol Sci 1995; 10:247-253.
10. Abassi Z, Goltsman I, Karram T, et al. Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol 2011; 2011:729497.
11. Tsuruda T, Boerrigter G, Huntley BK, et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 2002; 91:1127-1134.
12. Woodard GE, Rosado JA. Recent advances in natriuretic peptide research. J Cell Mol Med 2007; 11:1263-1271.
13. Charloux A, Piquard F, Doutreleau S, et al. Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest 2003; 33:769-778.
14. Klein JD. Corin: an ANP protease that may regulate sodium reabsorption in nephrotic syndrome. Kidney Int 2010; 78:635-637.
15. Ngo DT, Horowitz JD, Sverdlov AL. Heart failure: a corin-deficient state? Hypertension 2013; 61:284-285
16. Gladysheva IP, Wang D, McNamee RA, et al. Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension 2013; 61:327-332.
17. Bouley R. Corin: a key protein of an adaptive renal mechanism to respond to salt variation? Kidney Int 2012; 32:7-8.
18. Zhou Y, Jiang J, Cui Y, Wu Q. Corin, atrial natriuretic peptide and hypertension. Nephrol Dial Transplant 2009; 24:1071-1073.
19. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89-94.
20. Dries DL. Process matters: emerging concepts underlying impaired natriuretic peptide system function in heart failure. Circ Heart Fail 2011; 4:107-110.
21. Gardner DG, Chen S, Glenn DJ, Grigsby CL. Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension 2007; 49:419-426.
22. Beltowski J, Wojcicka G. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002; 8:RA39-RA52.
23. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-328.
24. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 2005; 26:901-932.
25. Maack T. Receptors of atrial-natriuretic-factor. Annu Rev Physiol 1992; 54:11-27.
26. Roques BP, Noble F, Dauge V, et al. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993; 45:87-146.
27. Abassi Z, Karram T, Ellaham S, et al. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004; 102:223-241.
28. Inagami T. Atrial natriuretic factor as a volume regulator. J Clin Pharmacol 1994; 34:424-426.
29. Silver MA. The natriuretic peptide system: kidney and cardiovascular effects. Curr Opin Nephrol Hypertens 2006; 15:14-21.
30. Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76:91-96.
31. Harris PJ, Thomas D, Morgan TO. Atrial natriuretic peptide inhibits angiotensin- stimulated proximal tubular sodium and water reabsorption. Nature 1987; 326:697-698.
32. Zeidel ML, Brady HR, Kone BC, et al. Endothelin, a peptide inhibitor of Na(+)- K(+)-ATPase in intact renal tubular epithelial cells. Am J Physiol 1989; 257:C1101-C1107.
33. Sonnenberg H. The physiology of atrial natriuretic factor. Can J Physiol Pharmacol 1987; 65:2021-2023.
34. Sonnenberg H, Honrath U, Chong CK, Wilson DR. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986; 250:F963-F966.
35. Curry FR. Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume. J Clin Invest 2005; 115:1458-1461.
36. Espiner EA. Physiology of natriuretic peptides [see comments]. J Intern Med 1994; 235:527-541.
37. Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 1995; 24:481-509.
38. Kleinert HD, Maack T, Atlas SA, et al. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6:I143-147.
39. Oikawa S, Imai M, Ueno A, et al. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide. Nature 1984; 309:724-726.
40. Vuolteenaho O, Arjamaa O, Ling N. Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. Biochem Biophys Res Commun 1985; 129:82-88.
41. Yan W, Wu F, Morser J, Wu Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U S A 2000; 97:8525-8529.
42. Gladysheva IP, Robinson BR, Houng AK, et al. Corin is co-expressed with pro- ANP and localized on the cardiomyocyte surface in both zymogen and catalytically active forms. J Mol Cell Cardiol 2008; 44:131-142.
43. Semenov AG, Tamm NN, Seferian KR, et al. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 2010; 56:1166-1176.
44. Sudoh T, Maekawa K, Kojima M, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 1989; 159:1427-1434.
45. Wu Q, Xu-Cai YO, Chen S, Wang W. Corin: new insights into the natriuretic peptide system. Kidney Int 2009; 75:142-146.
46. Yan W, Sheng N, Seto M, et al. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 1999; 274:14926-14935.
47. Chan JC, Knudson O, Wu F, et al. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci U S A 2005; 102:785-790.
48. Wu Q. The serine protease corin in cardiovascular biology and disease. Front Biosci 2007; 12:4179-4190.
49. Dong N, Chen S, Wang W, et al. Corin in clinical laboratory diagnostics. Clin Chim Acta 2012; 413:378-383.
50. Jiang J, Wu S, Wang W, et al. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. J Biol Chem 2011; 286:10066-10072.
51. Peleg A, Jaffe AS, Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clin Chim Acta 2009; 409:85-89.
52. Fang C, Shen L, Dong L, et al. Reduced urinary corin levels in patients with chronic kidney disease. Clin Sci (Lond) 2013; 124:709-717.
53. Raine AE, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315:533-537.
54. Burnett JCJ, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231:1145-1147.
55. Marenzi G, Lauri G, Guazzi M, et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci 2001; 321:359-366.
56. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87:464-469.
57. Wei CM, Kao PC, Lin JT, et al. Circulating beta-atrial natriuretic factor in congestive heart failure in humans. Circulation 1993; 88:1016-1020.
58. Ding J, Thibault G, Gutkowska J, et al. Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology 1987; 121: 248-257.
59. Hawkridge AM, Heublein DM, Bergen HR 3rd, et al. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 2005; 102:17442-17447.
60. Heublein DM, Huntley BK, Boerrigter G, et al. Immunoreactivity and guanosine 30,50-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 2007; 49:1114-1119.
61. Clerico A, Vittorini S, Passino C. Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. Adv Clin Chem 2012; 58:31-44.
62. Giuliani I, Rieunier F, Larue C, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006; 52:1054-1061.
63. Chimoskey JE, Spielman WS, Brandt MA, et al. Cardiac atria of Bio 14.6 hamsters are deficient in natriuretic factor. Science 1984; 223:820-822.
64. Miller WL, Phelps MA, Wood CM, et al. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail 2011; 4:355-360.
65. Langenickel TH, Pagel I, Buttgereit J, et al. Rat corin gene: molecular cloning and reduced expression in experimental heart failure. Am J Physiol Heart Circ Physiol 2004; 287:H1516-H1521.
66. Ichiki T, Boerrigter G, Huntley BK, et al. Differential expression of the pronatriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.AmJ Physiol Regul IntegrComp Physiol 2013; 304:R102-R109.
67. Tran KL, Lu X, Lei M, et al. Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. Am J Physiol Heart Circ Physiol 2004; 287:H1625-H1631.
68. Dong N, Chen S, Yang J, et al. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010; 3:207-211.
69. Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of proatrial natriuretic peptide. Circ Heart Fail 2011; 4:114-120.
70. Chen S, Sen S, Young D, et al. Protease corin expression and activity in failing hearts. Am J Physiol Heart Circ Physiol 2010; 299:H1687-H1692.
71. Dries DL, Victor RG, Rame JE, et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 2005; 112:2403-2410.
72. Rame JE, Tam SW, McNamara D, et al. Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circ Heart Fail 2009; 2:541-548.
73. Wang W, Liao X, Fukuda K, et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res 2008; 103:502-508.
74. Buckley CL, Stokes AJ. Corin-deficient W-sh mice poorly tolerate increased cardiac afterload. Regul Pept 2011; 172:44-50.
75. Abassi Z, Shuranyi E, Better OS, Winaver J. Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome. J Am Soc Nephrol 1992; 2:1538-1544.
76. Polzin D, Kaminski HJ, Kastner C, et al. Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases. Kidney Int 2010; 7:2010; 8:650-659.
77. Wang W, Shen J, Cui Y, et al. Impaired sodium excretion and salt-sensitive hypertension in corin-deficient mice. Kidney Int 2012; 82:26-33.
78. Wang W, Cui Y, Shen J, et al. Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks. Hypertension 2012; 60:1352-1358.
79. Cui Y, Wang W, Dong N, et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature 2012; 484:246-250.
80. Zhou Y, Wu Q. Role of corin and atrial natriuretic peptide in preeclampsia. Placenta 2013; 34:89-94.
81. Knappe S, Wu F, Madlansacay MR, Wu Q. Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. J Biol Chem 2004; 279:34464-34471.